Geode Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1M | Buy |
|
|||||
|
2025
Q1 | $22.9M | Sell |
|
|||||
|
2024
Q4 | $22.1M | Sell |
|
|||||
|
2024
Q3 | $30M | Buy |
|
|||||
|
2024
Q2 | $24.8M | Buy |
|
|||||
|
2024
Q1 | $28.5M | Buy |
|
|||||
|
2023
Q4 | $22.5M | Buy |
|
|||||
|
2023
Q3 | $15.9M | Buy |
|
|||||
|
2023
Q2 | $14.8M | Buy |
|
|||||
|
2023
Q1 | $15.4M | Buy |
|
|||||
|
2022
Q4 | $14.4M | Buy |
|
|||||
|
2022
Q3 | $9.7M | Buy |
|
|||||
|
2022
Q2 | $10.7M | Sell |
|
|||||
|
2022
Q1 | $12.4M | Buy |
|
|||||
|
2021
Q4 | $11.3M | Sell |
|
|||||
|
2021
Q3 | $12.1M | Sell |
|
|||||
|
2021
Q2 | $14.7M | Buy |
|
|||||
|
2021
Q1 | $13.9M | Buy |
|
|||||
|
2020
Q4 | $10.5M | Buy |
|
|||||
|
2020
Q3 | $10.5M | Sell |
|
|||||
|
2020
Q2 | $8.89M | Buy |
|
|||||
|
2020
Q1 | $7.97M | Buy |
|
|||||
|
2019
Q4 | $8.75M | Buy |
|
|||||
|
2019
Q3 | $4.68M | Buy |
|
|||||
|
2019
Q2 | $5.3M | Buy |
|
|||||
|
2019
Q1 | $5.5M | Buy |
|
|||||
|
2018
Q4 | $5.45M | Buy |
|
|||||
|
2018
Q3 | $4.22M | Buy |
|
|||||
|
2018
Q2 | $5.4M | Buy |
|
|||||
|
2018
Q1 | $5.14M | Buy |
|
|||||
|
2017
Q4 | $3.54M | Buy |
|
|||||
|
2017
Q3 | $1.86M | Buy |
|
|||||
|
2017
Q2 | $2.13M | Buy |
|
|||||
|
2017
Q1 | $1.47M | Buy |
|
|||||
|
2016
Q4 | $2.21M | Buy |
|
|||||
|
2016
Q3 | $2.03M | Buy |
|
|||||
|
2016
Q2 | $1.01M | Buy |
|
|||||
|
2016
Q1 | $1.43K | Buy |
|
|||||
|
2015
Q4 | $1.24M | Buy |
|
|||||
|
2015
Q3 | $839K | Buy |
|